NovoCure Limited Share Price & Technical Analysis
NVCR · $17.96 (+0.34%)
Healthcare / Medical Devices
$17.96
+0.34%
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTF…
Price chart
Seasonality
May has 5 positive and 0 negative years (last 5 years shown)
16% return in May, 31% avg return in past 3 year May month.
40% return in 2026, -34% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -6% | 11% | -19% | 38% | 16% | – | – | – | – | – | – | – | 40% |
| 25 | -20% | -20% | -6% | 2% | 4% | -7% | -34% | 8% | 5% | 0% | 0% | 7% | -62% |
| 24 | -5% | 9% | 1% | -22% | 80% | -25% | 32% | -15% | -11% | -1% | 31% | 6% | 80% |
| 23 | 23% | -16% | -22% | 10% | 9% | -43% | -21% | -32% | -27% | -17% | -6% | 21% | -122% |
| 22 | -10% | 18% | 2% | -8% | 5% | -13% | -2% | 21% | -6% | -7% | 6% | -5% | 1% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Strong · Strong
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$2.09B
P/E ratio
—
52W high
$20.06
52W low
$9.82
Volume
8,48,886
Beta
0.90
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is NovoCure Limited share price today?
- NovoCure Limited (NVCR) last traded around $17.96 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does NVCR have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for NVCR. Download the app for real-time alerts.
- How can I analyze NovoCure Limited stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.